<![CDATA[Chugai Pharmaceutical: News Releases]]> https://www.chugai-pharm.co.jp/english/index.html en-us Mon, 18 May 2026 15:30:00 +0900 <![CDATA[Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic of Alecensa for ALK Fusion Gene-Positive Solid Tumors]]> https://www.chugai-pharm.co.jp/english/news/detail/20260518153000_1244.html Mon, 18 May 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260518153000_1244.html <![CDATA[Alecensa Receives the World-First Tumor-Agnostic Approval for ALK Fusion Gene-Positive Solid Tumors Across Adult and Pediatric Patients]]> https://www.chugai-pharm.co.jp/english/news/detail/20260518153001_1249.html Mon, 18 May 2026 15:30:01 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260518153001_1249.html <![CDATA[Filing of Humanized Anti-CD20 Monoclonal Antibody Gazyva for Additional Indication of Idiopathic Nephrotic Syndrome]]> https://www.chugai-pharm.co.jp/english/news/detail/20260514153000_1250.html Thu, 14 May 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260514153000_1250.html <![CDATA[Chugai’s Pharmaceutical Packaging Leveraging Proprietary Technologies Wins the “WorldStar Winner 2026” at the “WorldStar Global Packaging Awards 2026” from the World Packaging Organization]]> https://www.chugai-pharm.co.jp/english/news/detail/20260511153000_1251.html Mon, 11 May 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260511153000_1251.html <![CDATA[Organizational and Personnel Changes]]> https://www.chugai-pharm.co.jp/english/news/detail/20260424170001_1245.html Fri, 24 Apr 2026 17:00:01 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260424170001_1245.html <![CDATA[Chugai Announces 2026 1st Quarter Results]]> https://www.chugai-pharm.co.jp/english/news/detail/20260424170002_1247.html Fri, 24 Apr 2026 17:00:02 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260424170002_1247.html <![CDATA[Determination of Details Regarding Share Acquisition Associated with the Introduction of the Trust-Based Stock Compensation System]]> https://www.chugai-pharm.co.jp/english/news/detail/20260424170000_1248.html Fri, 24 Apr 2026 17:00:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260424170000_1248.html <![CDATA[F. Hoffmann-La Roche Announces First Quarter Sales 2026]]> https://www.chugai-pharm.co.jp/english/news/detail/20260423140000_1242.html Thu, 23 Apr 2026 14:00:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260423140000_1242.html <![CDATA[FJ3, API Manufacturing Building for Small Molecule and Macrocyclic Peptide Drugs at the Fujieda Plant, Receives the 2026 Facility of the Year Awards from ISPE in the Honorable Mention Category]]> https://www.chugai-pharm.co.jp/english/news/detail/20260422163000_1243.html Wed, 22 Apr 2026 16:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260422163000_1243.html <![CDATA[Roche’s Announcement Regarding New Data of Enspryng for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)]]> https://www.chugai-pharm.co.jp/english/news/detail/20260422153000_1246.html Wed, 22 Apr 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260422153000_1246.html